← Leaderboards
Douglas L Fraker
University Of Pennsylvania
$813,455
Attributed
$813,455
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$813,455 · 3
By mechanism
T32$540,049 · 1
M01$273,406 · 1
P01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Meenhard Herlyn$50,214,821
- Lewis A Chodosh$38,386,361
- Marcelo Gabriel Kazanietz$22,841,058
- Gustavo David Aguirre$22,398,317
- Stephen G Emerson$28,932,839
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical Trial Phase IClinical ResearchGene DosageGene TherapyLiver NeoplasmsMetastasisNeoplasm /Cancer TherapyP53 Gene /ProteinPhotosensitizing AgentsPatient Oriented ResearchNeoplasm /Cancer Photoradiation TherapyDogsDrug Administration Rate /DurationPeritoneum NeoplasmNonhuman Therapy EvaluationCytokineHuman Therapy Evaluation
Grant awards (11)
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM$208,502
T32 · FY2002 · CA
GENE THERAPY FOR PRIMARY &METASTATIC MALIGNANT TUMORS OF LIVER$124,146
M01 · FY2002 · RR
OPTIMIZATION OF INTRAPERITONEAL PDT$0
P01 · FY2002 · CA
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM$196,846
T32 · FY2001 · CA
GENE THERAPY FOR PRIMARY &METASTATIC MALIGNANT TUMORS OF LIVER$124,146
M01 · FY2001 · RR
GENE THERAPY FOR PRIMARY &METASTATIC MALIGNANT TUMORS OF LIVER$0
M01 · FY2001 · RR
OPTIMIZATION OF INTRAPERITONEAL PDT$0
P01 · FY2001 · CA
SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM$134,701
T32 · FY2000 · CA
GENE THERAPY FOR PRIMARY &METASTATIC MALIGNANT TUMORS OF LIVER$25,114
M01 · FY2000 · RR
GENE THERAPY FOR PRIMARY &METASTATIC MALIGNANT TUMORS OF LIVER$0
M01 · FY2000 · RR
GENE THERAPY FOR PRIMARY &METASTATIC MALIGNANT TUMORS OF LIVER$0
M01 · FY2000 · RR